VolitionRx Awarded $1.5 Million in Non-Dilutive Funding

/PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, has announced it has been awarded a further $1.5...

Related Keywords

Walloon Region ,Waals Gewest ,Belgium ,United States ,United Kingdom ,London ,City Of ,Singapore ,America ,Louise Batchelor Debra Daglish ,Gaetan Michel ,Renaud Hattiez ,Exchange Commission ,Securities Exchange ,Prnewswire Volitionrx Limited ,Namur Invest Capital Risk ,Chief Operating Officer ,Namur Invest ,Director General ,Key Opinion Leaders ,Debra Daglish ,Securities Act ,Securities Exchange Act ,Annual Report ,Quarterly Reports ,Volitionrx Limited ,